Workflow
眼科用药
icon
Search documents
上市公司动态 | 招商轮船终止分拆子公司重组上市,牧原股份拟港股上市
He Xun Wang· 2025-05-28 00:08
Group 1 - China Merchants Energy announced the termination of the restructuring plan for its subsidiaries, China Merchants Container Shipping and China Merchants Roll-on Roll-off, due to lack of consensus on transaction terms and changes in market conditions [1] - The company will maintain its current equity structure, while Antong Holdings will take over the controlling stake of the subsidiaries [1] - China Merchants Container Shipping operates 30 vessels with a total capacity of 47,678 TEU, ranking 34th among global liner companies [1] Group 2 - Muyuan Foods has submitted an application for the issuance and listing of H-shares on the Hong Kong Stock Exchange, with the application materials published on the exchange's website [1] - In 2024, Muyuan Foods achieved a revenue of 137.947 billion yuan, a year-on-year increase of 24.43%, and a net profit of 18.925 billion yuan, up 554.07% [2] - The company sold 71.602 million pigs, including 65.477 million market pigs and 1.2524 million slaughtered pigs, with pork product sales totaling 141,590 tons [2] Group 3 - Optoelectronics Co. received approval from the China Securities Regulatory Commission for its application to issue shares to specific investors [3] - Xingqi Eye Medicine plans to raise no more than 850 million yuan through a private placement of shares for research and development center construction and working capital [4] - Jinyang Co. intends to issue convertible bonds to raise no more than 980 million yuan for lithium battery precision components projects and working capital [5] Group 4 - Nanjing Chemical Fiber received approval from the Jiangsu Provincial State-owned Assets Supervision and Administration Commission for a major asset swap and fundraising plan [8] - Zhongcheng Co. plans to acquire 100% equity of Zhongji Jiangsu and raise funds from no more than 35 specific investors, enhancing its capabilities in energy storage projects [8] Group 5 - Guotai Haitong plans to increase its capital by 1.5 billion yuan to Guotai Junan Futures for net capital supplementation [9] - Zhinan Compass's chairman resigned due to personal reasons, with the vice chairman temporarily taking over the responsibilities [10] Group 6 - Youa Co. intends to acquire 100% equity of Shenzhen Shangyangtong for 1.58 billion yuan, marking a strategic shift into the power semiconductor sector [11] - ST Dongjing is planning a change in control, with stock suspension starting from May 28, 2025, due to negotiations with a third party [12] - Su Shi Testing plans to acquire 23.73% equity of its subsidiary Su Shi Yite for 336 million yuan, increasing its stake from 73.82% to 97.55% [13] Group 7 - Wangzi New Materials elected Wang Jinjun as chairman and appointed him as CEO for a three-year term [14] - Nanjing Public Utilities plans to merge its wholly-owned subsidiary to optimize management structure and reduce costs [14] - Western Securities plans to issue up to 1 billion yuan in technology innovation corporate bonds to supplement working capital [14] Group 8 - Lutianhua intends to acquire 100% equity of Luzhou Hongsheng Chemical Park Operations for 676 million yuan, facilitating its project implementation [15] - Camel Group elected Liu Changle as chairman during its board meeting [15] - Yapu Co. plans to purchase approximately 54.5% of Yingshuang Technology for about 578 million yuan to enhance its automotive parts strategy [15] Group 9 - Luoping Zinc Electric is planning a change in control, with stock suspension starting from May 28, 2025, pending regulatory approval [16]
兴齐眼药(300573):一季度利润增长显著 费用管理卓有成效
Xin Lang Cai Jing· 2025-05-01 06:50
毛利率进一步提升,销售费用率明显下降 2024 年,公司整体毛利率为78.33%,同比+0.96 个百分点;期间费用率56.47%,同比-1.51 个百分点; 其中销售费用率36.30%,同比-0.17个百分点;研发费用率11.35%,同比-0.05;管理费用率8.76%,同 比-1.77 个百分点;财务费用率0.05%,同比+0.47 个百分点;经营性现金流净额为4.17 亿元,同比 +31.31%。 2025 年一季度,公司整体毛利率为80.16%,同比+4.05 个百分点;期间费用率47.26%,同比-17.21 个百 分点;其中销售费用率31.34%,同比-11.54 个百分点;研发费用率8.78%,同比-2.10 个百分点;管理费 用率6.97%,同比-4.09 个百分点;财务费用率0.18%,同比+0.52个百分点;经营性现金流净额为1.91 亿 元,同比+128.46%。 事件 2025 年4 月22 日,兴齐眼药发布2024 年年报,报告期内实现营业收入19.43 亿元,同比+32.42%;归母 净利润3.38 亿元,同比+40.84%;扣非归母净利润3.48 亿元,同比+44.54%。 事件 ...